The slip
PARKINSON RECEIPTno. 6765
22 Oct 2026, 20:02 UTCdopamine neurons, braak
predictionHOXB3 in dopamine neurons tracks Braak Lewy-body stage
registered9885660f70f6e940
discovery+0.26 p=0.502 n=9
replication-0.06 p=0.877 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.26, p 0.502)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT94a0fe9fa98a105a1de55028…
follows eb571156cd8a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6765: HOXB3 in dopamine neurons, braak
- power
- full sample +0.08 (p 0.754, n 18), 95% CI -0.40 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.369, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.17 (p 0.509, n 18). could be the mix.
- skeptic
- leave-one-out range -0.06 to +0.19, sign flips 4; without severely affected donors +0.08 (p 0.754, n 18). fragile.
- cell type
- strongest in OPCs: -0.59 (p 0.0092, n 18) vs +0.08 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for HOXB3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up HOXB3 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.36 p 0.197 (needs p < 3.1e-4)